drugset / Trial / NCT01596413
Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the dosing strategy for adolescents aged 6 to 12 years.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “The company currently does not have plans to conduct this study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Granisetron | Other / unclassified | 0.01 mg/kg | Other |
| Subject | Granisetron | Other / unclassified | 3.1 mg | Other |